Privia Health Group, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Privia Health Group, Inc. (PRVA) reported Net Income (Loss) Attributable to Noncontrolling Interest of $686.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-06
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $686.00K, a 14.14% increase year-over-year.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $646.00K, a 64.62% decline year-over-year.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.43M, a 48.14% increase year-over-year.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $2.95M, a 565.01% increase year-over-year.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $6.81M, a 156.00% increase from fiscal 2024.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $2.66M.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$2.05M.
- Privia Health Group, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$3.48M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $686.00K 10-Q · filed 2026-08-06 | $1.33M 10-Q · filed 2026-08-06 | $2.77M derived: sum of 3 quarters · filed 2026-08-06 | $5.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $646.00K 10-Q · filed 2026-05-07 | $2.08M derived: sum of 2 quarters · filed 2026-05-07 | $5.03M derived: sum of 3 quarters · filed 2026-05-07 | $5.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.38M derived: sum of 2 quarters · filed 2026-02-27 | $4.98M derived: sum of 3 quarters · filed 2026-08-06 | $6.81M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.95M 10-Q · filed 2025-11-06 | $3.55M derived: sum of 2 quarters · filed 2026-08-06 | $5.37M 10-Q · filed 2025-11-06 | $6.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $601.00K 10-Q · filed 2026-08-06 | $2.43M 10-Q · filed 2026-08-06 | $3.40M derived: sum of 3 quarters · filed 2026-08-06 | $3.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.83M 10-Q · filed 2026-05-07 | $2.79M derived: sum of 2 quarters · filed 2026-05-07 | $3.24M derived: sum of 3 quarters · filed 2026-05-07 | $4.41M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $968.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.41M derived: sum of 2 quarters · filed 2026-02-27 | $2.59M derived: sum of 3 quarters · filed 2026-02-27 | $2.66M 10-K · filed 2026-02-27 |
| 2024-09-30 | $443.00K 10-Q · filed 2025-11-06 | $1.62M derived: sum of 2 quarters · filed 2025-11-06 | $1.69M 10-Q · filed 2025-11-06 | $1.18M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.18M 10-Q · filed 2025-08-07 | $1.25M 10-Q · filed 2025-08-07 | $734.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.03M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-08 | -$442.00K derived: sum of 2 quarters · filed 2026-02-27 | -$143.00K derived: sum of 3 quarters · filed 2026-02-27 | -$1.06M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$215.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.13M derived: sum of 3 quarters · filed 2026-02-27 | -$2.05M 10-K · filed 2026-02-27 |
| 2023-09-30 | $299.00K 10-Q · filed 2024-11-07 | -$615.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.54M 10-Q · filed 2024-11-07 | -$2.46M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$914.00K 10-Q · filed 2024-08-08 | -$1.84M 10-Q · filed 2024-08-08 | -$2.76M derived: sum of 3 quarters · filed 2025-02-27 | -$3.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$922.00K 10-Q · filed 2024-05-09 | -$1.85M derived: sum of 2 quarters · filed 2025-02-27 | -$2.92M derived: sum of 3 quarters · filed 2025-02-27 | -$3.82M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$928.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.00M derived: sum of 2 quarters · filed 2025-02-27 | -$2.90M derived: sum of 3 quarters · filed 2025-02-27 | -$3.48M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.07M 10-Q · filed 2023-11-03 | -$1.97M derived: sum of 2 quarters · filed 2023-11-03 | -$2.55M 10-Q · filed 2023-11-03 | -$2.46M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$906.00K 10-Q · filed 2023-08-03 | -$1.48M 10-Q · filed 2023-08-03 | -$1.39M derived: sum of 3 quarters · filed 2024-02-27 | -$3.17M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$577.00K 10-Q · filed 2023-05-04 | -$487.00K derived: sum of 2 quarters · filed 2024-02-27 | -$2.26M derived: sum of 3 quarters · filed 2024-02-27 | -$3.21M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.69M derived: sum of 2 quarters · filed 2024-02-27 | -$2.64M derived: sum of 3 quarters · filed 2024-02-27 | -$2.42M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$1.78M 10-Q · filed 2022-11-10 | -$2.73M derived: sum of 2 quarters · filed 2022-11-10 | -$2.51M 10-Q · filed 2022-11-10 | -$2.59M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$951.00K 10-Q · filed 2022-08-11 | -$733.00K 10-Q · filed 2022-08-11 | -$818.00K derived: sum of 3 quarters · filed 2023-03-01 | -$903.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $218.00K 10-Q · filed 2022-05-12 | $133.00K derived: sum of 2 quarters · filed 2023-03-01 | $48.00K derived: sum of 3 quarters · filed 2023-03-01 | -$37.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$170.00K derived: sum of 2 quarters · filed 2023-03-01 | -$255.00K derived: sum of 3 quarters · filed 2023-03-01 | -$340.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$85.00K 10-Q · filed 2021-11-08 | -$170.00K derived: sum of 2 quarters · filed 2021-11-08 | -$255.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$85.00K 10-Q · filed 2021-08-09 | -$170.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$85.00K 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | -$299.00K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |